ODP Announcement 22-060 provides a News Alert from the Infection Prevention Specialist Partnership with Health Care Quality Units with information regarding performing COVID testing, treatment, and up-to-date COVID-19 vaccine booster dose recommendations.
The Office of Developmental Programs (ODP) has received funding through a Pennsylvania Department of Health (DOH) grant from the U.S. Centers for Disease Control and Prevention (CDC) appropriation under the 2019 Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) — Enhanced Detection Expansion (EDE) Grant.
This grant funding is being used to build capacity and provide additional support for infection prevention and control through the Health Care Quality Units (HCQUs) in partnership with a team of infection prevention specialists from Infectious Disease (ID) Connect. This project will run through June 2023.
A separate informational News Alert regarding Monkeypox is also available.
- It is a rare disease caused by the monkeypox virus belonging to the Orthopoxvirus genus.
- It was first discovered in 1958.
- The majority of the infections are in Democratic Republic of Congo.
- Cases outside of Africa are linked to international travel or imported animals.
- Rodents and non-human primates harbor the virus.
- 19 cases have been confirmed since 6/1/22.
- It is unclear how cases were exposed, but early data suggests that gay, bisexual, and other men who have sex with men make up a high number of cases.
- But, this does NOT mean that it is a sexually transmitted disease approved vaccine in this group.
For more information, please contact your regional HCQU contacts are listed in the ODP Announcement.